All Stories

  1. OTUB2 silencing promotes ovarian cancer via mitochondrial metabolic reprogramming and can be synthetically targeted by CA9 inhibition

    Article • Proceedings of the National Academy of Sciences, May 2024, Proceedings of the National Academy of Sciences

    Zhihua Liu

  2. Reflections on the withdrawal of medical articles and the development of writing and publishing standards

    Article • Cancer Biology and Medicine, September 2022, Tsinghua University Press

    Zhihua Liu

  3. USP48 Sustains Chemoresistance and Metastasis in Ovarian Cancer

    Article • Current Cancer Drug Targets, September 2020, Bentham Science Publishers

    Zhihua Liu